000303023 001__ 303023
000303023 005__ 20250722114136.0
000303023 0247_ $$2doi$$a10.1038/s41598-025-07894-7
000303023 0247_ $$2pmid$$apmid:40670423
000303023 0247_ $$2pmc$$apmc:PMC12267414
000303023 037__ $$aDKFZ-2025-01470
000303023 041__ $$aEnglish
000303023 082__ $$a600
000303023 1001_ $$aDiexer, Sophie$$b0
000303023 245__ $$aCross-sectional study of health impairment related to post COVID-19 condition among participants of a large population-based cohort in Germany.
000303023 260__ $$a[London]$$bSpringer Nature$$c2025
000303023 3367_ $$2DRIVER$$aarticle
000303023 3367_ $$2DataCite$$aOutput Types/Journal article
000303023 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753097959_5173
000303023 3367_ $$2BibTeX$$aARTICLE
000303023 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303023 3367_ $$00$$2EndNote$$aJournal Article
000303023 520__ $$aPost COVID-19 condition (PCC) is a substantial burden for patients, society, and the healthcare system. Participants of the German National Cohort (NAKO) were asked in an online survey about their self-perceived health, symptoms related to PCC, and infection status. PCC was defined as reporting symptoms for the time window 4-12 months after infection. Of 110,375 respondents (73% response), 86,833 were included in this analysis. Of these, 44,451 (51%) did not report a SARS-CoV-2 infection (no infection), 26,726 (31%) reported an infection but no symptoms 4-12 months after infection (infection/no PCC), and 15,656 (18%) reported an infection and symptoms (PCC). The median number of current symptoms at the time of the survey was two for the 'no infection' and the 'infection/no PCC' group, and five for the 'PCC' group. Participants with PCC had a substantially higher probability of having worse self-perceived health (OR 1.84, 95% CI [1.75; 1.93] compared to the 'no infection' group, adjusting for sex, age, education and chronic diseases with elevated risk for developing PCC. After adjusting for the number of current symptoms related to PCC, this difference disappeared, suggesting that the symptoms collected explain the impairment of self-perceived health in the PCC group.
000303023 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000303023 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303023 650_2 $$2MeSH$$aHumans
000303023 650_2 $$2MeSH$$aCOVID-19: epidemiology
000303023 650_2 $$2MeSH$$aCOVID-19: complications
000303023 650_2 $$2MeSH$$aGermany: epidemiology
000303023 650_2 $$2MeSH$$aFemale
000303023 650_2 $$2MeSH$$aMale
000303023 650_2 $$2MeSH$$aMiddle Aged
000303023 650_2 $$2MeSH$$aCross-Sectional Studies
000303023 650_2 $$2MeSH$$aAdult
000303023 650_2 $$2MeSH$$aAged
000303023 650_2 $$2MeSH$$aSARS-CoV-2: isolation & purification
000303023 650_2 $$2MeSH$$aSurveys and Questionnaires
000303023 650_2 $$2MeSH$$aHealth Status
000303023 650_2 $$2MeSH$$aCohort Studies
000303023 650_2 $$2MeSH$$aPost-Acute COVID-19 Syndrome
000303023 7001_ $$aFrost, Jonas$$b1
000303023 7001_ $$aAhnert, Peter$$b2
000303023 7001_ $$aBaernighausen, Till W$$b3
000303023 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b4$$udkfz
000303023 7001_ $$aFricke, Julia$$b5
000303023 7001_ $$aGabrysch, Sabine$$b6
000303023 7001_ $$0P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aGreiser, Karin-Halina$$b7$$udkfz
000303023 7001_ $$aHarth, Volker$$b8
000303023 7001_ $$aHeise, Jana-Kristin$$b9
000303023 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b10$$udkfz
000303023 7001_ $$aKarch, André$$b11
000303023 7001_ $$aKeil, Thomas$$b12
000303023 7001_ $$aKlee, Bianca$$b13
000303023 7001_ $$aKlett-Tammen, Carolina J$$b14
000303023 7001_ $$aKrist, Lilian$$b15
000303023 7001_ $$aLampl, Benedikt M J$$b16
000303023 7001_ $$aLeitzmann, Michael F$$b17
000303023 7001_ $$aLieb, Wolfgang$$b18
000303023 7001_ $$aMeinke-Franze, Claudia$$b19
000303023 7001_ $$aMichels, Karin B$$b20
000303023 7001_ $$aVelásquez, Ilais Moreno$$b21
000303023 7001_ $$aObi, Nadia$$b22
000303023 7001_ $$aPeters, Annette$$b23
000303023 7001_ $$aPfrommer, Laura R$$b24
000303023 7001_ $$aPischon, Tobias$$b25
000303023 7001_ $$aPurschke, Oliver$$b26
000303023 7001_ $$aRübsamen, Nicole$$b27
000303023 7001_ $$aSchikowski, Tamara$$b28
000303023 7001_ $$aSchmidt, Börge$$b29
000303023 7001_ $$aThierry, Sigrid$$b30
000303023 7001_ $$aVölzke, Henry$$b31
000303023 7001_ $$aWright, Marvin N$$b32
000303023 7001_ $$aZeeb, Hajo$$b33
000303023 7001_ $$aMikolajczyk, Rafael$$b34
000303023 773__ $$0PERI:(DE-600)2615211-3$$a10.1038/s41598-025-07894-7$$gVol. 15, no. 1, p. 25830$$n1$$p25830$$tScientific reports$$v15$$x2045-2322$$y2025
000303023 909CO $$ooai:inrepo02.dkfz.de:303023$$pVDB
000303023 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000303023 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000303023 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000303023 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000303023 9141_ $$y2025
000303023 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSCI REP-UK : 2022$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-07-29T15:28:26Z
000303023 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-07-29T15:28:26Z
000303023 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-07-29T15:28:26Z
000303023 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-18
000303023 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-18
000303023 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebs$$x0
000303023 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie der Krebsfrüherkennung$$x1
000303023 980__ $$ajournal
000303023 980__ $$aVDB
000303023 980__ $$aI:(DE-He78)C020-20160331
000303023 980__ $$aI:(DE-He78)C070-20160331
000303023 980__ $$aUNRESTRICTED